Target intelligence / Profile preview

Fat absorption pathway

Molecular classification
Other
01

Overview

The **fat absorption pathway** refers to the physiological process by which dietary fats are digested and absorbed in the gastrointestinal tract. This is not a single molecule or receptor but rather a complex sequence involving multiple enzymes (such as lingual, gastric, and pancreatic lipases), bile acids for emulsification, transporters on enterocytes for uptake, intracellular reassembly into triglycerides within intestinal cells, packaging into chylomicrons for lymphatic transport, and eventual release into systemic circulation[1][2][3][7]. The process is essential for energy supply to the body as well as for the uptake of critical nutrients like cholesterol and fat-soluble vitamins. Disorders affecting any step can result in malabsorption syndromes characterized by steatorrhea and nutritional deficiencies[3]. **Note:** "Fat absorption pathway" is not a canonical molecular target but rather describes an entire physiological process involving many proteins/enzymes/receptors. Therefore, *is_incorrect* = true; this entry does not correspond to a specific druggable target but instead encompasses multiple components involved in lipid digestion/absorption[1][2][3].

Other names
Lipid absorption pathwayIntestinal fat absorptionLipid digestion and absorption
02

Mechanism of action

Inhibition of digestive enzymes (e.g., pancreatic lipase inhibitors reduce triglyceride breakdown and thus fat absorption) - Disruption of micelle formation or bile acid recycling impairs emulsification and uptake of fats

03

Biological functions

Nutrient absorptionEnergy homeostasisTransport of fat-soluble vitamins
04

Disease associations

Malabsorption syndromesSteatorrheaFat-soluble vitamin deficiency
05

Safety considerations

Risk of deficiencies in essential fatty acids and fat-soluble vitamins with impaired or pharmacologically inhibited pathways[3]Gastrointestinal side effects such as steatorrhea with drugs that block the pathway[3]
06

Interacting drugs

Orlistat (inhibits pancreatic lipase)

1 more in the full profile.

07

Biomarkers

Fecal fat quantification (for malabsorption)Serum levels of fat-soluble vitamins (A, D, E, K)

Beyond the preview

Go deeper on Fat absorption pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fat absorption pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call